300858 Stock Overview
Researches, develops, manufactures, and sells probiotic lactic acid bacteria and related products in China.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Beijing Scitop Bio-tech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.33 |
| 52 Week High | CN¥21.41 |
| 52 Week Low | CN¥13.81 |
| Beta | 0.60 |
| 11 Month Change | -9.19% |
| 3 Month Change | -22.12% |
| 1 Year Change | -8.96% |
| 33 Year Change | -42.95% |
| 5 Year Change | n/a |
| Change since IPO | 13.36% |
Recent News & Updates
Shareholder Returns
| 300858 | CN Food | CN Market | |
|---|---|---|---|
| 7D | -2.8% | -1.3% | -1.4% |
| 1Y | -9.0% | -20.4% | -19.1% |
Return vs Industry: 300858 exceeded the CN Food industry which returned -20.4% over the past year.
Return vs Market: 300858 exceeded the CN Market which returned -19.1% over the past year.
Price Volatility
| 300858 volatility | |
|---|---|
| 300858 Average Weekly Movement | 6.0% |
| Food Industry Average Movement | 5.7% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in CN Market | 10.0% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 300858's share price has been volatile over the past 3 months.
Volatility Over Time: 300858's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 330 | Xiaojun Liu | www.scitop.cn |
Beijing Scitop Bio-tech Co., Ltd. researches, develops, manufactures, and sells probiotic lactic acid bacteria and related products in China. It also provides probiotic materials, compound ingredients, food additives, and animal and plant microecological preparations. Its products have applications in the food industry, health care, animal husbandry, and agricultural planting.
Beijing Scitop Bio-tech Co., Ltd. Fundamentals Summary
| 300858 fundamental statistics | |
|---|---|
| Market cap | CN¥3.78b |
| Earnings (TTM) | CN¥91.94m |
| Revenue (TTM) | CN¥286.12m |
41.1x
P/E Ratio13.2x
P/S RatioIs 300858 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300858 income statement (TTM) | |
|---|---|
| Revenue | CN¥286.12m |
| Cost of Revenue | CN¥128.61m |
| Gross Profit | CN¥157.51m |
| Other Expenses | CN¥65.56m |
| Earnings | CN¥91.94m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 21, 2024
| Earnings per share (EPS) | 0.35 |
| Gross Margin | 55.05% |
| Net Profit Margin | 32.14% |
| Debt/Equity Ratio | 0% |
How did 300858 perform over the long term?
See historical performance and comparison